Evaluation of the biotinidase activity in hepatic glycogen storage disease patients. Undescribed genetic finding associated with atypical enzymatic behavior: an outlook
- PMID: 20532819
- DOI: 10.1007/s10545-010-9139-x
Evaluation of the biotinidase activity in hepatic glycogen storage disease patients. Undescribed genetic finding associated with atypical enzymatic behavior: an outlook
Abstract
Repeated evaluation of biotinidase (BTD) activity was carried out for a long-term follow-up in patients with hepatic glycogen storage diseases (GSDs). The results indicated inter-intra variability among the GSD-Ia, GSD-III and GSD-IX patients. In addition, a c.1330G>C transversion in the BTD gene, resulting in a p.Asp444His substitution was detected in one allele of a GSD-Ia patient with sustained normal enzyme activity. Thus far, it is necessary to be cautious in the interpretation of the results of BTD activity as a presumptive GSD diagnostic element. It is not known why plasma BTD activity increases in GSDs patients, or the clinical importance of the increment. When viewed from a global perspective, there are some lines of biotin biology that could indicate a relationship between BTD´s behavior and GSDs.
Similar articles
-
Biomarkers in Glycogen Storage Diseases: An Update.Int J Mol Sci. 2021 Apr 22;22(9):4381. doi: 10.3390/ijms22094381. Int J Mol Sci. 2021. PMID: 33922238 Free PMC article. Review.
-
Elevated serum biotinidase activity in hepatic glycogen storage disorders--a convenient biomarker.J Inherit Metab Dis. 2007 Nov;30(6):896-902. doi: 10.1007/s10545-007-0734-4. Epub 2007 Nov 12. J Inherit Metab Dis. 2007. PMID: 17994282
-
Markedly elevated serum biotinidase activity may indicate glycogen storage disease type Ia.J Inherit Metab Dis. 2003;26(8):805-9. doi: 10.1023/B:BOLI.0000009949.65855.4c. J Inherit Metab Dis. 2003. PMID: 14739685
-
Genotypic and phenotypic features of 39 Chinese patients with glycogen storage diseases type I, VI, and IX.Clin Genet. 2024 Sep;106(3):267-276. doi: 10.1111/cge.14530. Epub 2024 Apr 5. Clin Genet. 2024. PMID: 38576397
-
Diagnosis of hepatic glycogen storage disease patients with overlapping clinical symptoms by massively parallel sequencing: a systematic review of literature.Orphanet J Rare Dis. 2020 Oct 14;15(1):286. doi: 10.1186/s13023-020-01573-8. Orphanet J Rare Dis. 2020. PMID: 33054851 Free PMC article.
Cited by
-
Glycogen storage diseases: An update.World J Gastroenterol. 2023 Jul 7;29(25):3932-3963. doi: 10.3748/wjg.v29.i25.3932. World J Gastroenterol. 2023. PMID: 37476587 Free PMC article. Review.
-
Understanding Glycogen Storage Disease Type IX: A Systematic Review with Clinical Focus-Why It Is Not Benign and Requires Vigilance.Genes (Basel). 2025 May 15;16(5):584. doi: 10.3390/genes16050584. Genes (Basel). 2025. PMID: 40428406 Free PMC article. Review.
-
Biomarkers in Glycogen Storage Diseases: An Update.Int J Mol Sci. 2021 Apr 22;22(9):4381. doi: 10.3390/ijms22094381. Int J Mol Sci. 2021. PMID: 33922238 Free PMC article. Review.
-
Proteomic and Genomic Methylation Signatures of Idiopathic Subglottic Stenosis.Laryngoscope. 2021 Feb;131(2):E540-E546. doi: 10.1002/lary.28851. Epub 2020 Jul 3. Laryngoscope. 2021. PMID: 32619300 Free PMC article.
-
Beyond predicting diagnosis: Is there a role for measuring biotinidase activity in liver glycogen storage diseases?Mol Genet Metab Rep. 2022 Feb 28;31:100856. doi: 10.1016/j.ymgmr.2022.100856. eCollection 2022 Jun. Mol Genet Metab Rep. 2022. PMID: 35782603 Free PMC article.
References
Publication types
MeSH terms
Substances
Supplementary concepts
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Miscellaneous